News >

Long-Term Evidence Supports Use of SBRT in Prostate Cancer

Kristi Rosa
Published: Wednesday, Feb 13, 2019

Amar U. Kishan, MD

Amar U. Kishan, MD

Stereotactic body radiation therapy (SBRT) has been found to be a safe and effective option for patients with low- and intermediate-risk prostate cancer, according to long-term outcome data recently published in JAMA Network Open.1



  1. Kishan AU, Dang A, Katz AJ, et al. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer. JAMA Netw Open. 2019;2(2):e188006. doi: 10.1001/jamanetworkopen.2018.8006.
  2. Shorter Course Of Radiation Therapy Effective In Treating Men With Prostate Cancer UCLA. Published February 8, 2019. Accessed February 12, 2019.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™Aug 30, 20201.5
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Publication Bottom Border
Border Publication